Speed Post News Network
New Delhi : Union Finance & Corporate Affairs Minister Nirmala Sitharaman praised the Indian Industry for its extreme forbearance, patience and perseverance, and described it with Japanese word ‘Gamanzuyoi’. She was addressing more than 150 senior industry captains in a virtual interaction organised by the Confederation of Indian Industry (CII) here on April 21, 2021.
Sitharaman emphasised on the need for adopting micro containment strategy in dealing with the 2nd surge of the pandemic and acknowledged that the deliberations with CII had helped shape this strategy. Explaining the rationale, the Finance Minister (FM) said that unlike last time we now have important tools such as vaccine and medicine to deal with the pandemic.
On meeting the phenomenal increase in demand for medical oxygen, a critical treatment tool for COVID-19, the Finance Minister assured seamless supply to states. Measures that the government is taking include importing medical oxygen, round the clock working of the oxygen filling stations, and allowing containers used for nitrogen and argon to be used for oxygen, she added.
The FM also gave details of Government initiatives to help ramp up capacity of Remdesivir from 36 lakh vials per month to 78 lakh vials per month. Some of these measures include rapid clearances for new capacities, stopping exports, stopping the exports of APIs, and formulations used in the manufacture of this life saving drug, and allowing EoUs and manufacturers located in SEZs to also sell in the domestic market, Sse said.
During the interaction, the CII members manufacturing Remdesivir informed the Finance Minister that they were working towards exceeding the committed target of 78 lakh vials per month and aiming to reach a production of 1 crore vials per month.
Elaborating on the recent announcements on the vaccination, the Finance Minister said that the CII’s suggestions on opening up of the vaccination to all adults, allowing industry to vaccinate its employees and their families, and allowing vaccine imports have all been accepted in the policy. The Government has also cleared an advance payment of Rs 4,600 crore to Serum Institute of India and Bharat Bio Tech to help them ramp up capacities, the FM said, according to a PIB release.
Welcoming the CII suggestions on mitigating the impact to the economy to save livelihoods, alongside lives, the Finance Minister assured an examination of the same.
Earlier, Uday Kotak, President CII and Managing Director & CEO, Kotak Mahindra Bank Limited, in his opening remarks lauded the speed of Government’s policy action for tackling the COVID-19 pandemic over the last 72 hours. He emphasised on the importance of vaccination and doing whatever it takes to ramp up vaccination. He also emphasised on ensuring adequate supplies of oxygen, medicine, and beds in the immediate term. In the medium term, he emphasised on ramping up research to identify and tackle the mutants and to upgrade the vaccine. He also suggested to build India’s capacity in terms of supplies and medical infrastructure to address any possible future waves.